BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11859130)

  • 1. Dendritic cells transduced with protein antigens induce cytotoxic lymphocytes and elicit antitumor immunity.
    Shibagaki N; Udey MC
    J Immunol; 2002 Mar; 168(5):2393-401. PubMed ID: 11859130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgene IL-6 enhances DC-stimulated CTL responses by counteracting CD4+25+Foxp3+ regulatory T cell suppression via IL-6-induced Foxp3 downregulation.
    Bhanumathy KK; Zhang B; Ahmed KA; Qureshi M; Xie Y; Tao M; Tan X; Xiang J
    Int J Mol Sci; 2014 Mar; 15(4):5508-21. PubMed ID: 24690994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
    Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
    Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penetratin tandemly linked to a CTL peptide induces anti-tumour T-cell responses via a cross-presentation pathway.
    Pouniotis DS; Apostolopoulos V; Pietersz GA
    Immunology; 2006 Mar; 117(3):329-39. PubMed ID: 16476052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful tumor eradication was achieved by collaboration of augmented cytotoxic activity and anti-angiogenic effects following therapeutic vaccines containing helper-activating analog-loaded dendritic cells and tumor antigen DNA.
    Teramoto K; Kontani K; Fujita T; Ozaki Y; Sawai S; Tezuka N; Fujino S; Itoh Y; Taguchi O; Kannagi R; Ogasawara K
    Cancer Immunol Immunother; 2007 Mar; 56(3):331-42. PubMed ID: 16896967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell-leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination.
    Galea-Lauri J; Darling D; Mufti G; Harrison P; Farzaneh F
    Cancer Immunol Immunother; 2002 Aug; 51(6):299-310. PubMed ID: 12111118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant gemcitabine therapy negatively affects DC vaccine-induced CD8(+) T-cell and B-cell responses but improves clinical efficacy in a murine pancreatic carcinoma model.
    Bauer C; Sterzik A; Bauernfeind F; Duewell P; Conrad C; Kiefl R; Endres S; Eigler A; Schnurr M; Dauer M
    Cancer Immunol Immunother; 2014 Apr; 63(4):321-33. PubMed ID: 24384835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced anti-tumor immunity by superantigen-pulsed dendritic cells.
    Kato M; Nakamura Y; Suda T; Ozawa Y; Inui N; Seo N; Nagata T; Koide Y; Kalinski P; Nakamura H; Chida K
    Cancer Immunol Immunother; 2011 Jul; 60(7):1029-38. PubMed ID: 21519830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cells loaded with exogenous antigen by electroporation can enhance MHC class I-mediated antitumor immunity.
    Kim KW; Kim SH; Jang JH; Lee EY; Park SW; Um JH; Lee YJ; Lee CH; Yoon S; Seo SY; Jeong MH; Lee ST; Chung BS; Kang CD
    Cancer Immunol Immunother; 2004 Apr; 53(4):315-22. PubMed ID: 14685778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salmonella enterica serovar typhimurium-induced maturation of bone marrow-derived dendritic cells.
    Svensson M; Johansson C; Wick MJ
    Infect Immun; 2000 Nov; 68(11):6311-20. PubMed ID: 11035740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-peptide-pulsed dendritic cells isolated from spleen or cultured in vitro from bone marrow precursors can provide protection against tumor challenge.
    Hermans IF; Daish A; Moroni-Rawson P; Ronchese F
    Cancer Immunol Immunother; 1997 Aug; 44(6):341-7. PubMed ID: 9298937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mannosylated mucin-type immunoglobulin fusion proteins enhance antigen-specific antibody and T lymphocyte responses.
    Ahlén G; Strindelius L; Johansson T; Nilsson A; Chatzissavidou N; Sjöblom M; Rova U; Holgersson J
    PLoS One; 2012; 7(10):e46959. PubMed ID: 23071675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poliovirus vaccine vectors elicit antigen-specific cytotoxic T cells and protect mice against lethal challenge with malignant melanoma cells expressing a model antigen.
    Mandl S; Sigal LJ; Rock KL; Andino R
    Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8216-21. PubMed ID: 9653167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of Synthetic Long Peptides and XCL1 Fusion Proteins Results in Superior Tumor Control.
    Botelho NK; Tschumi BO; Hubbell JA; Swartz MA; Donda A; Romero P
    Front Immunol; 2019; 10():294. PubMed ID: 30863405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heteroclitic immunization induces tumor immunity.
    Dyall R; Bowne WB; Weber LW; LeMaoult J; Szabo P; Moroi Y; Piskun G; Lewis JJ; Houghton AN; Nikolić-Zugić J
    J Exp Med; 1998 Nov; 188(9):1553-61. PubMed ID: 9802967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immunotherapy approach with dendritic cells genetically modified to express the tumor-associated antigen, HER2.
    Nabekura T; Nagasawa T; Nakauchi H; Onodera M
    Cancer Immunol Immunother; 2008 May; 57(5):611-22. PubMed ID: 17786440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor activity of dendritic cells transfected with mRNA for receptor for hyaluronan-mediated motility is mediated by CD4+ T cells.
    Fukui M; Ueno K; Suehiro Y; Hamanaka Y; Imai K; Hinoda Y
    Cancer Immunol Immunother; 2006 May; 55(5):538-46. PubMed ID: 16025267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transience of MHC Class I-restricted antigen presentation after influenza A virus infection.
    Mintern JD; Bedoui S; Davey GM; Moffat JM; Doherty PC; Turner SJ
    Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6724-9. PubMed ID: 19346476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo detection of dendritic cell antigen presentation to CD4(+) T cells.
    Ingulli E; Mondino A; Khoruts A; Jenkins MK
    J Exp Med; 1997 Jun; 185(12):2133-41. PubMed ID: 9182685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-loaded Monocyte Administration and Flt3 Ligand Augment the Antitumor Efficacy of Immune Checkpoint Blockade in a Murine Melanoma Model.
    D'Anniballe VM; Huang MN; Lueck BD; Nicholson LT; McFatridge I; Gunn MD
    J Immunother; 2023 Nov-Dec 01; 46(9):333-340. PubMed ID: 37737688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.